Table 4.
Drugs used as comparators for disproportionality analysis.
| Drug Category | Drug | Pharmacologic Class |
|---|---|---|
| Anticoagulant drugs | Heparin | Unfractionated heparin |
| Dalteparin | Low molecular weight heparin | |
| Enoxaparin | Low molecular weight heparin | |
| Nadroprin | Low molecular weight heparin | |
| Tinzaparin | Low molecular weight heparin | |
| Reviparin | Low molecular weight heparin | |
| Parnaparin | Low molecular weight heparin | |
| Certoparin | Low molecular weight heparin | |
| Bemiparin | Low molecular weight heparin | |
| Semuloparin | Low molecular weight heparin | |
| Deligoparin | Low molecular weight heparin | |
| Fondaparinux | Parenteral direct factor Xa inhibitor | |
| Danaparoid | Heparinoid | |
| Pentosan polysulphate | Heparinoid | |
| Argatroban | Parenteral direct thrombin inhibitor | |
| Desirudin | Parenteral direct thrombin inhibitor | |
| Lepirudin | Parenteral direct thrombin inhibitor | |
| Bivalirudin | Parenteral direct thrombin inhibitor | |
| Warfarin | VKA | |
| Acenocoumarol | VKA | |
| Dicumarol | VKA | |
| Phenindione | VKA | |
| Anisindione | VKA | |
| Fluindione | VKA | |
| Antiplatelet drugs | Clopidogrel | Platelet aggregation inhibitors |
| Ticagrelor | Platelet aggregation inhibitors | |
| Prasugrel | Platelet aggregation inhibitors | |
| Ticlopidine | Platelet aggregation inhibitors | |
| Cilostazol | Phosphodiesterase type 3 inhibitor | |
| Triflusal | Platelet aggregation inhibitors | |
| Abciximab | Glycoprotein platelet inhibitors | |
| Eptifibatide | Glycoprotein platelet inhibitors | |
| Tirofiban | Glycoprotein platelet inhibitors | |
| Vorapaxar | Protease-activated receptor-1 antagonists | |
| Dipyridamole | Nucleoside transport and phosphodiesterase type 3 inhibitor | |
| Dipyridamole and Acetylsalicylic acid | Combination | |
| Acetylsalicylic acid and Clopidogrel | Combination |